2021-01-06,Akari Therapeutics to Participate in Two January Virtual Investor Conferences
2020-12-11,Akari Therapeutics Reports Third Quarter 2020 Financial Results  and Highlights Recent Clinical Progress
2020-12-11,Akari Therapeutics Announces New Clinical Data that Show Long-Term Self-Administered Nomacopan is Well-Tolerated and Substantially Reduces Transfusion Dependence in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)
2020-12-03,Akari Therapeutics Announces Publication in American Journal of Pathology Highlighting Potential of Nomacopan in Treatment of Uveitis and Retinal Disease
2020-11-30,Akari Therapeutics (NASDAQ:AKTX) Will Have To Spend Its Cash Wisely
2020-10-27,Akari Therapeutics to Present Phase II Data from Bullous Pemphigoid Trial at European Academy of Dermatology and Venereology (EADV) Virtual Congress October 29
2020-10-06,Akari Therapeutics Announces Further Clinical Trial Progress Using Nomacopan to Treat COVID-19 Pneumonia
2020-09-29,Akari Therapeutics to Present Its Phase III Plans at the International Pemphigus & Pemphigoid Foundation (IPPF) Patient Education Conference
2020-09-10,Akari Therapeutics to Participate in Two September Virtual Investor Conferences
2020-09-02,"Have Insiders Been Buying Akari Therapeutics, Plc (NASDAQ:AKTX) Shares?"
2020-09-01,Akari Therapeutics Reports Second Quarter 2020 Financial Results  and Highlights Recent Clinical Progress
2020-08-31,Akari Therapeutics Announces International Clinical Development Program of Nomacopan for the Potential Treatment of COVID-19 Pneumonia
2020-08-12,Akari Therapeutics Announces Successful End-of-Phase II Meeting With FDA to Initiate Pivotal Phase III Study for Treatment of Bullous Pemphigoid With Nomacopan
2020-07-01,"Akari Therapeutics Enters into a Securities Purchase Agreement for up to $30 Million with Aspire Capital Fund, LLC"
2020-07-01,Akari Therapeutics Announces Appointment of Chief Financial Officer
2020-06-25,3 Biotech Stocks Under $5 With 100%-Plus Upside Potential
2020-05-29,Akari Therapeutics Reports First Quarter 2020 Financial Results and Highlights Recent Clinical Progress
2020-05-21,Akari Therapeutics Receives Positive EMA Opinion on Orphan Designation for Nomacopan for Bullous Pemphigoid
2020-05-04,Akari Therapeutics to Participate in STRH Life Sciences Virtual Meeting Series
2020-05-01,Akari Therapeutics Announces Positive Topline Results from Fully Recruited Phase II Study of Nomacopan in Bullous Pemphigoid Patients
2020-03-31,Akari Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Business Highlights
2020-03-04,"Akari Therapeutics, Plc Announces Closing of $9.5 Million Private Placement"
2020-02-21,"The Daily Biotech Pulse: FDA Approves Baudax Bio's Non-Opioid Pain Drug, Aerie Rallies On Q4 Results, D-Day For Esperion"
2020-02-20,"Akari Therapeutics, Plc Announces Private Placement"
2020-01-27,Akari Therapeutics Announces Preclinical Ophthalmic Data Showing Nomacopan Reduces Both Vascular Endothelial Growth Factor (VEGF) and Retinal Inflammation Supporting Nomacopan as a Potential Treatment Option for Back-of-the-Eye Diseases
2020-01-10,Akari Therapeutics Announces Positive Interim Data from Phase III Paroxysmal Nocturnal Hemoglobinuria (PNH) Study
2019-12-23,Akari Therapeutics Announces Initiation of Pivotal Phase III Trial of Nomacopan in Pediatric Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy (HSCT-TMA) Following the Opening of its IND
2019-12-02,"Akari Therapeutics Announces Pivotal Phase III Trial Design of Nomacopan in Pediatric Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy (HSCT-TMA), Following FDA Meeting"
2019-11-18,"What Kind Of Shareholder Owns Most Akari Therapeutics, Plc (NASDAQ:AKTX) Stock?"
2019-11-04,Akari Therapeutics Reports Third Quarter 2019 Financial Results And Highlights Recent Clinical Progress
2019-10-14,Akari Therapeutics Announces New Data from Atopic Keratoconjunctivitis (AKC) Patients Supporting the Potentially Beneficial Role of Nomacopan as an Inhibitor of both C5 and LTB4 in the Ongoing Phase I/II AKC Trial
2019-10-10,Akari Therapeutics Announces Positive Phase II Clinical Data in Orphan Blistering Skin Disease Bullous Pemphigoid at the 28th EADV Congress
2019-10-10,"The Daily Biotech Pulse: UCB To Buy Ra Pharma, Reata Reacquires Rights To Nrf2 Activators From AbbVie, BioNTech IPO"
2019-10-06,"The Week Ahead In Biotech: Pfenex And Clinuvel On The Radar Ahead of FDA Decisions, 2 IPOs On Deck"
2019-09-19,"How Much Cash Is Left In The Bank For Akari Therapeutics, Plc (NASDAQ:AKTX)?"
2019-09-18,Akari Therapeutics to Participate in Ladenburg Thalmann Healthcare Conference
2019-09-16,Akari's Nomacopan Gets Orphan Drug Tag for Rare Skin Disease
2019-09-13,Akari Therapeutics Nomacopan Granted U.S. Orphan Drug Designation for Bullous Pemphigoid
2019-09-04,"Biotech Stock Roundup: REGN Wins Against AMGN, VRTX to Acquire Semma &amp; More"
2019-09-03,Akari Therapeutics to Participate in Citi and H.C. Wainwright Conferences in Early September
2019-09-02,Akari's Nomacopan Gets Orphan Drug Tag for Rare Disease
2019-08-30,"A Look At Benzinga Pro's Most-Searched Tickers For August 30, 2019"
2019-08-30,"The Daily Biotech Pulse: Genmab-Novartis Multiple Sclerosis Drug Aces Late-Stage Studies, Akari Nets Orphan Drug Designation"
2019-08-30,Akari's 2-Day Rally: What You Need To Know
2019-08-30,Akari Therapeutics shares soar 13% premarket after FDA grants Orphan Drug designation to nomacopan
2019-08-30,Akari Therapeutics Nomacopan Granted U.S. Orphan Drug Designation for Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy (HSCT-TMA)
2019-08-29,Akari Therapeutics Reports Second Quarter 2019 Financial Results And Highlights Recent Clinical Progress
2019-08-15,"A Look At Benzinga Pro's Most-Searched Tickers For August 15, 2019"
2019-08-14,Biopharma News: Why Akari Therapeutics (AKTX) Stock Is Soaring Today
2019-08-14,Akari Therapeutics' stock rockets on heavy volume after FDA grants nomacopan 'Fast Track' designation
2019-08-14,Akari Therapeutics Receives FDA Fast Track Designation for Nomacopan for Pediatric Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy (HSCT-TMA)
2019-08-09,Akari Therapeutics announces new data demonstrating synergistic benefits of nomacopans bifunctional C5 and LTB4 inhibitory activity in pemphigoid disease
2019-07-31,"Akari Therapeutics Announces Oral Presentation of Nomacopan Phase II Data in Patients with Bullous Pemphigoid at the 28th European Academy of Dermatology and Venereology (EADV) Congress, October 9-13, 2019"
2019-07-17,"Before You Buy Akari Therapeutics, Plc (NASDAQ:AKTX), Consider Its Volatility"
2019-07-04,Alexion's Ultomiris Receives EU Approval for PNH in Adults
2019-06-28,"Akari Therapeutics, Plc Announces $4.5 Million Registered Direct Offering"
2019-06-28,Alexion Receives FDA Approval for Label Expansion of Soliris
2019-06-21,Alexion's sBLA for Ultomiris Gets Priority Review From FDA
2019-06-20,Akari (AKTX) Eye Candidate Proves Safety in Early-Stage Study
2019-06-19,"Akari's Lead Candidate Found Safe, Effective In Treating Eye Inflammation"
2019-06-19,Akari Therapeutics Nomacopan Demonstrates Positive Early Safety and Efficacy in Phase I/II Clinical Study in Moderate-to-Severe Atopic Keraconjunctivitis (AKC)
2019-05-29,Akari Therapeutics Reports First Quarter 2019 Financial Results And Highlights Recent Clinical Progress
2019-04-29,FDA Events Put Healthcare Stocks In The Headlines: Here's One That No One's Talking About Yet
2019-04-26,Akari Therapeutics Announces Expanded Ophthalmology Program Based on Positive Emerging Data on LTB4-C5 Dual Action in Surface and Back of the Eye Diseases
2019-04-24,"The Daily Biotech Pulse: FDA Greenlights AbbVie's Psoriasis Drug, Novartis Earnings, Patent Notification For MediciNova"
2019-04-23,Akari Reports Fourth Quarter and Full Year 2018 Financial Results and Business Highlights
2019-04-23,"Positive News in The Biotech, Social Media, Financial & Cannabis Sectors Help the Market Towards New Highs"
2019-04-23,Microcap Biotech Akari Rallies On Coversin Trial Results
2019-04-23,Akari Therapeutics Announces Positive Initial Phase II Clinical Data in Orphan Skin Disease Bullous Pemphigoid
2019-03-27,Akari Therapeutics to Provide Update on its Eye Disease Program During Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
2019-03-18,These Tech Stocks Could Test March Highs
2019-03-14,"What Kind Of Shareholders Own Akari Therapeutics, Plc (NASDAQ:AKTX)?"
2019-03-14,"The Daily Biotech Pulse: Arsanis Completes X4 Merger, EC Nod For Roche, Axovant Offering"
2019-03-13,These 4 Tech Stocks Are On The Rise On Wednesday (3/13/19)
2019-03-13,Akari Therapeutics' stock rockets on massive volume after 'successful' pre-IND FDA meeting
2019-03-13,Positive FDA Meeting Outlines Path Ahead for Akari Therapeuticss Coversin in Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy (HSCT-TMA)
2019-02-21,"Factors of Influence in 2019, Key Indicators and Opportunity within EnLink Midstream, Pepsico, Arista Networks, Maiden, GCI Liberty, and Akari Therapeutics  New Research Emphasizes Economic Growth"
2019-02-04,"Alexion's (ALXN) Earnings Beat Estimates in Q4, Shares Up"
2019-01-29,Alexion's Ultomiris Meets Primary Endpoint in aHUS Study
2018-12-26,"What You Must Know About Akari Therapeutics, Plcs (NASDAQ:AKTX) Beta Value"
2018-11-30,Akari Therapeutics Announces New Data Highlighting Differentiation of Drug Candidate Coversin
2018-11-15,Akari Announces Coversin Data to be Presented at 2018 Complement-Based Drug Development Summit
2018-11-15,Akari Announces Third Quarter 2018 Financial Results and Business Highlights
2018-10-25,"Factors of Influence in 2018, Key Indicators and Opportunity within Intersect ENT, Akari Therapeutics, Ampio Pharmaceuticals, Virtusa, Umpqua, and Hamilton Lane  New Research Emphasizes Economic Growth"
2018-09-30,Akari Therapeutics Announces New Clinical Data in Post-Transplant Thrombotic Microangiopathies. Data Supports Akaris Ongoing Clinical Expansion into a Range of Orphan Autoinflammatory Diseases That Are Either Mediated by Complement C5 or Have Synchronous LTB4 and C5 Activity
2018-09-27,Akari Announces Second Quarter 2018 Financial Results and Business Highlights
2018-09-27,"Akari Therapeutics Enters into a Securities Purchase Agreement for up to $20 Million with Aspire Capital Fund, LLC"
2018-09-25,Akari Therapeutics to Present at the Cantor Fitzgerald Global Healthcare Conference
2018-09-12,"Akari Therapeutics Announces New Preclinical Rheumatoid Arthritis Data and New Clinical Data in Patients with Bullous Pemphigoid, Highlighting Potential Advantages of Coversins bifunctional activity inhibiting both the Complement and Leukotriene Inflammatory Pathways"
2018-09-04,"Research Report Identifies Brady, Akari Therapeutics, MTGE Investment, Jones Lang LaSalle, New Relic, and Sorrento Therapeutics with Renewed Outlook  Fundamental Analysis, Calculating Forward Movement"
2018-08-20,"The Rosen Law Firm, P.A. Announces Proposed Class Action Settlement on Behalf of Purchasers of Securities of Akari Therapeutics, plc -- AKTX"
2018-08-17,Akari Announces First Quarter 2018 Financial Results and Update on its Growing Pipeline of Phase II and Phase III Clinical Trials
2018-06-15,Akari Therapeutics to Present Poster at the 23rd Congress of the European Hematology Association
2018-05-25,How Do Analysts See Akari Therapeutics Plc (NASDAQ:AKTX) Performing In The Years Ahead?
2018-05-25,"Market Trends Toward New Normal in Independent Bank, First Busey, American Public Education, The First Bancshares, Northfield, and Akari Therapeutics  Emerging Consolidated Expectations, Analyst Ratings"
2018-05-21,Akari Therapeutics Receives Notice Related to Delay in 20-F Filing
2018-05-16,Should You Buy Akari Therapeutics Plc (NASDAQ:AKTX) Now?
2018-04-16,Blog Exposure - Tetraphase Pharma Announced Data Presentations from IGNITE4 Study at 28th European Congress of Clinical Microbiology and Infectious Diseases
2018-04-03,"Analysis: Positioning to Benefit within ForeScout Technologies, CommerceHub, Newtek Business Services, Credit Acceptance, Akari Therapeutics, and Brady  Research Highlights Growth, Revenue, and Consolidated Results"
2018-03-21,Edited Transcript of AKTX earnings conference call or presentation 21-Mar-18 12:30pm GMT
